| Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306) |
|---|
| 02/19/2014 | EP2697247A1 Method for the rapid chemoenzymatic glycosylation of conjugates between peptides and hydrophilic polymers |
| 02/05/2014 | CN102268075B Glycopeptide drug-fast bacteria resisting antibiotic as well as preparation method and application thereof |
| 02/04/2014 | US8642729 Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases |
| 01/23/2014 | US20140024604 Glycopeptide phosphonate derivatives |
| 01/22/2014 | EP2686009A1 Method for preparing multiple antigen glycopeptide carbohydrate conjugates |
| 01/16/2014 | US20140017169 Caged cell penetrating peptide-polymer conjugates for diagnostic and therapeutic applications |
| 01/14/2014 | US8629114 Compositions and methods for transport across the blood brain barrier |
| 01/07/2014 | US8623378 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| 01/07/2014 | CA2286798C Alpha-o-linked glycoconjugates with clustered(2,6)-st epitopes, methods of preparation and uses thereof |
| 01/02/2014 | US20140004175 Angiopoietin derived peptides |
| 12/25/2013 | CN103467576A Separating and purifying method for obtaining highly pure teicoplanin |
| 12/19/2013 | US20130338338 Alpha-conotoxin peptides |
| 12/11/2013 | CN103435688A Novel method for preparing compound of natural glycosyl-1-phosphoryl dipeptide and phosphoramide |
| 12/11/2013 | CN101302248B Production method of high-purity teicoplanin |
| 12/05/2013 | US20130323187 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation |
| 12/03/2013 | CA2577854C Purification of glycopeptides |
| 11/27/2013 | CN103408640A Method for purifying teicoplanin |
| 11/27/2013 | CN103408639A Preparation method of vancomycin with high purity |
| 11/27/2013 | CN103408638A Preparation technology for vancomycin crystals |
| 11/26/2013 | US8591910 Chemically programmable immunity |
| 11/19/2013 | CA2305620C Method for the covalent attachment of polysaccharides to protein molecules |
| 11/14/2013 | US20130303727 Vancomycin b hydrochloride crystalline form 1 |
| 11/13/2013 | EP2661492A2 Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells |
| 11/12/2013 | US8580922 Peptide linkers for polypeptide compositions and methods for using same |
| 11/07/2013 | US20130295099 N-linkedglycan compounds |
| 11/05/2013 | US8575309 Delta-opioid receptor selective analgesics |
| 11/05/2013 | US8575305 Cell penetrating peptides |
| 11/05/2013 | US8575107 Clusterin derived peptide |
| 11/05/2013 | US8575103 Peptides and methods for inhibiting G alpha protein signaling |
| 10/31/2013 | US20130288955 Structural and mechanistic basis for novel compound biosynthesis using 4-electron hexose oxidase |
| 10/30/2013 | EP2657255A1 Aminated complex-type sugar chain derivatives and process for the production thereof |
| 10/30/2013 | EP2655353A1 Derivatives of glyco-cf2-serine and glyco-cf2-threonine |
| 10/23/2013 | CN103360470A Purification method for ramoplanin fermentation liquor |
| 10/22/2013 | US8563687 Synthetic genes for plant gums and other hydroxyproline rich glycoproteins |
| 10/22/2013 | CA2491594C Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| 10/15/2013 | US8557978 Cross-linked glycopeptide-cephalosporin antibiotics |
| 10/01/2013 | US8546527 Molecular weight markers for membrane proteins |
| 09/26/2013 | US20130251639 Novel Cyclodecapeptide Compounds For Use As Drugs |
| 09/25/2013 | CN103328460A Derivatives of glyco-CF2-serine and glyco-CF2-threonine |
| 09/24/2013 | US8541375 Glycopeptide phosphonate derivatives |
| 09/12/2013 | WO2013106851A3 Syncollin, pancreatic triacylglycerol lipase, and other biomarkers for diabetes |
| 09/11/2013 | CN103288920A Survivin-derived peptide and use thereof |
| 09/04/2013 | CN103275192A Separation and purification method of high-purity teicoplanin |
| 08/29/2013 | US20130224237 Inhibition of nonsense mediated decay pathways |
| 08/28/2013 | CN101906148B Survivin-derived peptides and use thereof |
| 08/22/2013 | US20130217027 Agents providing controls and standards for immuno-precipitation assays |
| 08/14/2013 | CN103242432A Method for synthesizing phosphoramidon by utilizing hydrogen phosphorous acid diester intermediate |
| 07/25/2013 | US20130190246 Collagen-binding synthetic peptidoglycans for use in vascular intervention |
| 07/24/2013 | CN103221537A Method of production of recombinant glycoproteins with increased circulatory half-ife in mammalian cells |
| 07/23/2013 | CA2487351C Export and modification of (poly)peptides in the lantibiotic way |
| 07/18/2013 | US20130184629 Skin treatment devices and methods with pre-stressed configurations |
| 07/17/2013 | CN103209701A Immunogenic vaccine |
| 07/16/2013 | US8487079 Use of mitochondria-targeted electron scavengers as anti-inflammatory agents |
| 07/16/2013 | US8487075 Alpha-conotoxin peptides |
| 07/10/2013 | EP2611823A1 Peptide containing multiple n-linked glycosylation sequons |
| 07/09/2013 | US8481678 Peptide-based tooth whitening reagents |
| 07/04/2013 | US20130171180 Derivatives of glyco-cf2-serine and glyco-cf2-threonine |
| 06/27/2013 | WO2013096697A2 Isolation, identification, and used of antifungal compounds |
| 06/11/2013 | US8461313 Conjugates and compositions for cellular delivery |
| 06/11/2013 | CA2426012C Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 06/05/2013 | CN101456903B Separation and purification method of vancocin |
| 05/29/2013 | CN102382178B Separation method of sialoglycopeptide |
| 05/28/2013 | US8450100 Collagen peptide having immune-enhancing activity from Cyanea nozakii and preparation method and uses thereof |
| 05/23/2013 | WO2013072838A1 Cationic antibacterial composition |
| 05/23/2013 | US20130131311 Aziridine mediated native chemical ligation |
| 05/23/2013 | CA2855753A1 Cationic antibacterial composition |
| 05/21/2013 | US8445006 Biomolecular coating for implants |
| 05/16/2013 | WO2013068538A1 Process of purification of teicoplanin |
| 05/16/2013 | WO2013068517A1 Process of purification of teicoplanin |
| 05/15/2013 | EP2592090A1 Process of purification of teicoplanin |
| 05/15/2013 | EP2592089A1 Process of purification of teicoplanin |
| 05/14/2013 | CA2521130C Acyl-phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis |
| 05/07/2013 | US8436140 Natriuretic peptide-mediated imaging of atherosclerotic plaque |
| 05/07/2013 | US8435491 Quantification method for remaining liver function and novel liver receptor imaging agent |
| 05/01/2013 | EP2586786A1 Sulphated amino sugars with anti-inflammatory properties |
| 04/24/2013 | CN103065754A Magnetic material for surface finish benzene sulfonic acid, and preparation method and application thereof |
| 04/18/2013 | US20130096275 Vancomycin b hydrochloride crystalline form 1 |
| 04/16/2013 | US8420774 Decorating hydroxyapatite biomaterials with modular biologically active molecules |
| 04/16/2013 | CA2555036C Antithrombotic compound |
| 04/11/2013 | US20130090284 Isolation, identification, and uses of antifungal compounds |
| 04/10/2013 | EP2578598A1 Componds derived from normuramyldipeptide |
| 04/10/2013 | CN103030684A Novel bleomycin analogue as well as preparation method and application thereof |
| 03/27/2013 | EP2571893A1 Novel cyclodecapeptide compounds for use as drugs |
| 03/27/2013 | CN102993275A Bleomycin derivatives and anti-tumour activity thereof |
| 03/27/2013 | CN101228442B Method of stabilizing peptide contained in biosample |
| 03/26/2013 | CA2485169C Peptide derivatives, and their use for the synthesis of silicon-based composite materials |
| 03/21/2013 | US20130072438 Opioid peptide esters and methods of use |
| 03/19/2013 | US8399656 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| 03/14/2013 | WO2013034676A1 Process for the synthesis of telavancin, its pharmaceutically acceptable salts as well as an n-protected imine-derivative of telavancin |
| 03/14/2013 | WO2013034675A1 Process for the synthesis of telavancin and its pharmaceutically acceptable salts as well as n-protected derivatives thereof |
| 03/13/2013 | CN102964430A Purification method of teicoplanin |
| 03/12/2013 | US8394921 N-terminal derivatisation of proteins with polysaccharides |
| 03/12/2013 | US8394362 Gem difluorinated C-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosugery |
| 03/05/2013 | US8389791 Treatment devices and methods with extending elements |
| 02/28/2013 | US20130055417 Hormone responsive tissue culture system and uses thereof |
| 02/28/2013 | US20130053543 Peptide clearing agents |
| 02/28/2013 | US20130052172 Methods for diagnosing and treating cardiac defects |
| 02/14/2013 | US20130041131 Glycosylated specificity exchangers |
| 02/14/2013 | US20130040886 Peptides and Methods for Inhibiting G alpha Protein Signaling |
| 02/14/2013 | US20130039948 Inhibition of TCR Signaling with Peptide Variants |